Bariatric Surgery 5 Times More Effective Than Ozempic for Weight Loss
A 2025 study from New York University (NYU) has revealed a significant gap in effectiveness between bariatric surgery and the popular class of GLP-1 receptor agonist medications, such as semaglutide, and tirzepatide. While these medications have gained widespread popularity for weight loss, the research suggests they may not be the most effective medical option for many patients.
Researchers compared patients who underwent gastric bypass or sleeve gastrectomy with those using medication, matching participants by age, body mass index (BMI), and glucose levels. The findings indicate that surgical intervention provides more substantial and durable results.
The Weight Loss Gap: Surgery vs. Medication
The study found that individuals who underwent bariatric surgery lost an average of 25.7% of their body weight over two years. In contrast, those treated with GLP-1 medications lost an average of only 5.3%.
Avery Brown, a surgical resident at NYU, noted that while clinical trials often show weight loss between 15% and 21% for GLP-1 drugs, real-world results are often much lower. This discrepancy is partly attributed to the fact that up to 70% of patients discontinue medication treatment within a year.
Understanding the Implications
The durability of surgical intervention is a primary factor in its success. While medications require strict, long-term adherence to maintain results, surgery offers a more permanent physiological change.
Ann M. Rogers, president of the American Society for Metabolic and Bariatric Surgery (ASMBS), emphasized that while both groups lose weight, metabolic and bariatric surgery is more effective and durable. However, the study also highlighted that surgery is an invasive and permanent procedure that still requires patients to maintain healthy lifestyles and strict diets.
Broad Health Benefits and Trade-offs
Despite the lower weight loss percentages in this study, GLP-1 medications provide other significant health advantages. Evidence suggests these drugs can reduce the risk of cardiovascular diseases and certain cancers.
Interestingly, the NYU study found that bariatric surgery was associated with even better glycemic control than the medications. This positions surgery not just as a weight loss tool, but as a potent metabolic intervention.
Future Directions in Obesity Treatment
The medical community may now shift focus toward optimizing how GLP-1 treatments are administered to improve patient retention. Future research could aim to identify which specific patient profiles are better suited for surgery versus medication.
researchers like Karan Chhabra from the NYU Grossman School of Medicine suggest that the role of out-of-pocket costs may be a key factor in treatment success. analysing these costs could be a possible next step in improving long-term health outcomes.
Frequently Asked Questions
What was the difference in weight loss between surgery and medication?
Patients who had bariatric surgery lost an average of 25.7% of their body weight over two years, while those on GLP-1 medications lost an average of 5.3%.
Why do medications show lower results in the real world than in clinical trials?
The study suggests that many patients do not adhere to medication long-term, with up to 70% of patients stopping treatment within one year.
Is bariatric surgery a perfect solution for weight loss?
No. While effective, This proves an invasive and permanent intervention that requires patients to continue following strict diets and healthy lifestyle habits.
Do you believe the permanence of surgery outweighs the convenience of medication for long-term health?